Free Trial
NASDAQ:LNTH

Lantheus (LNTH) Stock Price, News & Analysis

Lantheus logo
$55.50 -1.34 (-2.36%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$55.70 +0.20 (+0.35%)
As of 08:47 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Lantheus Stock (NASDAQ:LNTH)

Key Stats

Today's Range
$55.27
$56.96
50-Day Range
$51.87
$83.83
52-Week Range
$47.25
$118.21
Volume
1.06 million shs
Average Volume
2.60 million shs
Market Capitalization
$3.77 billion
P/E Ratio
14.76
Dividend Yield
N/A
Price Target
$105.50
Consensus Rating
Moderate Buy

Company Overview

Lantheus Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

LNTH MarketRank™: 

Lantheus scored higher than 95% of companies evaluated by MarketBeat, and ranked 56th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Lantheus has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Lantheus has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Lantheus' stock forecast and price target.
  • Earnings Growth

    Earnings for Lantheus are expected to grow by 4.99% in the coming year, from $6.01 to $6.31 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Lantheus is 14.76, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.74.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Lantheus is 14.76, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.27.

  • Price to Book Value per Share Ratio

    Lantheus has a P/B Ratio of 3.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Lantheus' valuation and earnings.
  • Percentage of Shares Shorted

    12.75% of the float of Lantheus has been sold short.
  • Short Interest Ratio / Days to Cover

    Lantheus has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Lantheus has recently increased by 2.31%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Lantheus does not currently pay a dividend.

  • Dividend Growth

    Lantheus does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.75% of the float of Lantheus has been sold short.
  • Short Interest Ratio / Days to Cover

    Lantheus has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Lantheus has recently increased by 2.31%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Lantheus has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 39 news articles for Lantheus this week, compared to 12 articles on an average week.
  • Search Interest

    23 people have searched for LNTH on MarketBeat in the last 30 days. This is an increase of 283% compared to the previous 30 days.
  • MarketBeat Follows

    8 people have added Lantheus to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Lantheus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $384,430,031.00 in company stock.

  • Percentage Held by Insiders

    Only 1.50% of the stock of Lantheus is held by insiders.

  • Percentage Held by Institutions

    99.06% of the stock of Lantheus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Lantheus' insider trading history.
Receive LNTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lantheus and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LNTH Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
13 High Growth Low PE Stocks to Invest In Now
Q3 Earnings Forecast for Lantheus Issued By Leerink Partnrs
See More Headlines

LNTH Stock Analysis - Frequently Asked Questions

Lantheus' stock was trading at $89.46 at the start of the year. Since then, LNTH shares have decreased by 38.0% and is now trading at $55.50.

Lantheus Holdings, Inc. (NASDAQ:LNTH) announced its quarterly earnings data on Wednesday, August, 6th. The medical equipment provider reported $1.57 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.65 by $0.08. The company's revenue for the quarter was down 4.1% on a year-over-year basis.
Read the conference call transcript
.

Lantheus (LNTH) raised $75 million in an initial public offering on Thursday, June 25th 2015. The company issued 7,900,000 shares at a price of $8.50-$10.50 per share. Citigroup, Jefferies, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

Top institutional investors of Lantheus include Geode Capital Management LLC (2.57%), Westfield Capital Management Co. LP (2.20%), Reinhart Partners LLC. (2.03%) and TD Asset Management Inc (0.91%). Insiders that own company stock include Lantheus Alpha Therapy, Llc, Farallon Partners L L C/Ca, Rajiv A Patel, Mary Anne Heino, Robert J Jr Marshall, Paul Blanchfield, Daniel Niedzwiecki, Etienne Montagut, Andrea Sabens, James H Thrall, Heinz Christoph Maeusli, Gerard Ber, Brian A Markison, Gary J Pruden and Minnie Baylor-Henry.
View institutional ownership trends
.

Shares of LNTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lantheus investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/06/2025
Today
8/28/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LNTH
CIK
1521036
Employees
700
Year Founded
N/A

Price Target and Rating

High Price Target
$175.00
Low Price Target
$63.00
Potential Upside/Downside
+90.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.76
Trailing P/E Ratio
14.76
Forward P/E Ratio
9.23
P/E Growth
N/A
Net Income
$312.44 million
Net Margins
17.82%
Pretax Margin
24.75%
Return on Equity
34.06%
Return on Assets
19.10%

Debt

Debt-to-Equity Ratio
0.49
Current Ratio
4.29
Quick Ratio
4.07

Sales & Book Value

Annual Sales
$1.53 billion
Price / Sales
2.46
Cash Flow
$6.93 per share
Price / Cash Flow
8.01
Book Value
$17.16 per share
Price / Book
3.23

Miscellaneous

Outstanding Shares
67,990,000
Free Float
66,974,000
Market Cap
$3.77 billion
Optionable
Optionable
Beta
0.14
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:LNTH) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners